These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1299998)

  • 1. [Role of adverse effects of immuno-allergic nature at a Regional Pharmacovigilance Center].
    Sorbette F; Conte S; Montastruc JL
    Therapie; 1992; 47(5):445-6. PubMed ID: 1299998
    [No Abstract]   [Full Text] [Related]  

  • 2. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system.
    Chen CJ; Cheng CF; Lin HY; Hung SP; Chen WC; Lin MS
    J Clin Pharm Ther; 2012 Dec; 37(6):647-51. PubMed ID: 22646235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center)].
    Ciorciaro C; Hartmann K; Kuhn M
    Schweiz Med Wochenschr; 1998 Feb; 128(7):254-8. PubMed ID: 9540150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-induced hyperglycemia: a study in the French pharmacovigilance database].
    Chebane L; Tavassoli N; Bagheri H; Montastruc JL;
    Therapie; 2010; 65(5):447-58. PubMed ID: 21144480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective study of adverse drug reactions in the elderly: experience of regional center for pharmacovigilance].
    Bruneau S; Bruhat C; Lagarce L; Lainé-Cessac P
    Therapie; 2001; 56(6):785-91. PubMed ID: 11878111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions in hospital patients.
    Buechner JS
    Med Health R I; 1998 Feb; 81(2):60-1. PubMed ID: 9505068
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria.
    Getov I; Dimitrova Z
    Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions in hospital and ambulatory care settings identified using a large administrative database.
    Kane-Gill SL; Van Den Bos J; Handler SM
    Ann Pharmacother; 2010 Jun; 44(6):983-93. PubMed ID: 20442350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse effects of oxybutynin chloride (Ditropan). Evaluation of the official survey of Regional Pharmacovigilance Centers].
    Jonville AP; Dutertre JP; Autret E; Barbellion M
    Therapie; 1992; 47(5):389-92. PubMed ID: 1299977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reaction surveillance in an emergency room.
    Stoukides CA; D'Agostino PR; Kaufman MB
    Am J Hosp Pharm; 1993 Apr; 50(4):712-4. PubMed ID: 8470691
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug-induced discoloration of the teeth and gingiva].
    Mosimann P; Hartmann K; Kuhn M
    Praxis (Bern 1994); 1998 Mar; 87(12):413-6. PubMed ID: 9564238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients.
    Seeger JD; Kong SX; Schumock GT
    Pharmacotherapy; 1998; 18(6):1284-9. PubMed ID: 9855328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions among children over a 10-year period.
    Le J; Nguyen T; Law AV; Hodding J
    Pediatrics; 2006 Aug; 118(2):555-62. PubMed ID: 16882807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre study.
    Chalabianloo F; Berstad A; Schjøtt J; Riedel B; Irgens A; Florvaag E
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):506-13. PubMed ID: 21523851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statistical considerations on the activity of the Clinica Tossicologica of the University of Florence in the years 1959 to 1964].
    Mannaioni PF; Morichi G; Guidotti A; Ledda F
    Clin Ter; 1966 Dec; 39(6):527-38. PubMed ID: 5999282
    [No Abstract]   [Full Text] [Related]  

  • 17. Study dispels assumptions about adverse drug events.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Aug; 12(17):1-2, 5. PubMed ID: 12296363
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal.
    P S; P M; Pr S
    Pak J Pharm Sci; 2008 Oct; 21(4):465-7. PubMed ID: 18930872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication administration: how safe is your patient?
    Am J Nurs; 1995 Oct; 95(10):44-59; quiz 60. PubMed ID: 7573208
    [No Abstract]   [Full Text] [Related]  

  • 20. [Critical analysis of the adverse effects reported to the Paris-Fernand Widal Drug Monitoring Center in a 2-month period].
    Castot A; Carlier P; Lagier G; Elmalem J; Vincens M; Efthymiou M
    Therapie; 1986; 41(5):375-7. PubMed ID: 3810528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.